Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)

Vertex Pharmaceuticals Statistics

Total Valuation

BVMF:VRTX34 has a market cap or net worth of BRL 583.40 billion. The enterprise value is 529.51 billion.

Market Cap	583.40B
Enterprise Value	529.51B

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	0.21%
Owned by Institutions (%)	95.90%
Float	252.91M

Valuation Ratios

The trailing PE ratio is 29.79 and the forward PE ratio is 21.30.

PE Ratio	29.79
Forward PE	21.30
PS Ratio	9.34
PB Ratio	6.32
P/TBV Ratio	6.93
P/FCF Ratio	32.80
P/OCF Ratio	29.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.41, with an EV/FCF ratio of 29.77.

EV / Earnings	27.04
EV / Sales	8.53
EV / EBITDA	20.41
EV / EBIT	22.04
EV / FCF	29.77

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.11.

Current Ratio	2.36
Quick Ratio	1.84
Debt / Equity	0.11
Debt / EBITDA	0.37
Debt / FCF	0.55
Interest Coverage	354.41

Financial Efficiency

Return on equity (ROE) is 22.31% and return on invested capital (ROIC) is 15.51%.

Return on Equity (ROE)	22.31%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	15.51%
Return on Capital Employed (ROCE)	22.25%
Revenue Per Employee	10.24M
Profits Per Employee	3.21M
Employee Count	6,100
Asset Turnover	0.50
Inventory Turnover	4.10

Taxes

In the past 12 months, BVMF:VRTX34 has paid 4.12 billion in taxes.

Income Tax	4.12B
Effective Tax Rate	17.39%

Stock Price Statistics

The stock price has decreased by -21.16% in the last 52 weeks. The beta is 0.32, so BVMF:VRTX34's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-21.16%
50-Day Moving Average	544.30
200-Day Moving Average	619.37
Relative Strength Index (RSI)	60.42
Average Volume (20 Days)	164

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.71

Income Statement

In the last 12 months, BVMF:VRTX34 had revenue of BRL 62.48 billion and earned 19.59 billion in profits. Earnings per share was 75.80.

Revenue	62.48B
Gross Profit	32.94B
Operating Income	24.18B
Pretax Income	23.71B
Net Income	19.59B
EBITDA	25.11B
EBIT	24.18B
Earnings Per Share (EPS)	75.80

Balance Sheet

The company has 33.51 billion in cash and 9.78 billion in debt, giving a net cash position of 54.23 billion.

Cash & Cash Equivalents	33.51B
Total Debt	9.78B
Net Cash	54.23B
Net Cash Per Share	n/a
Equity (Book Value)	92.30B
Book Value Per Share	363.45
Working Capital	32.48B

Cash Flow

In the last 12 months, operating cash flow was 19.81 billion and capital expenditures -2.03 billion, giving a free cash flow of 17.79 billion.

Operating Cash Flow	19.81B
Capital Expenditures	-2.03B
Free Cash Flow	17.79B
FCF Per Share	n/a

Margins

Gross margin is 52.72%, with operating and profit margins of 38.70% and 31.35%.

Gross Margin	52.72%
Operating Margin	38.70%
Pretax Margin	37.95%
Profit Margin	31.35%
EBITDA Margin	40.19%
EBIT Margin	38.70%
FCF Margin	28.47%

Dividends & Yields

BVMF:VRTX34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	3.36%
FCF Yield	3.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:VRTX34 has an Altman Z-Score of 11.3 and a Piotroski F-Score of 5.

Altman Z-Score	11.3
Piotroski F-Score	5